Study of Changes in CSF Ionic Composition After Aneurysmal Meningeal Hemorrhage
- Conditions
- Subarachnoid Hemorrhage
- Registration Number
- NCT05942755
- Lead Sponsor
- Hospices Civils de Lyon
- Brief Summary
Hyponatremia is a frequent complication of subarachnoid hemorrhage (SAH) with a prevalence of 30 to 50% in patients with this condition. This hydro-electrolytic disorder is responsible for an increase in morbidity with the appearance of neurological disorders.
Also, it has been shown that there are ionic changes in the cerebrospinal fluid and a probable alteration of the blood-brain barrier in patients with SAH. The kinetics and relationship between hyponatremia and these changes remain unknown.
The main objective of the study is to determine whether the change in cerebrospinal fluid (CSF) composition, precedes the development of hyponatremia. For this, the investigators propose to study the evolution of the CSF ionogram with the blood ionogram. Furthermore, they will perform additional analyses on the basis of a control group (CSF of patient with normal pressure hydrocephalus) to determine the effect of SAH on ionic changes.
The hypothesis of the study is that there is a correlation between the change in CSF blood ionogram and the development of hyponatremia between day 0 and day 14.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 80
SAH group :
- Adults
- Hospitalized in the neurological intensive care unit for a Fisher modified aneurysmal SAH 3 or 4 with EVD and urinary catheter.
- With a catheter (arterial or venous) for repeated sampling.
Control group :
- Adults
- Performing a perfusion test in the operating room for normal pressure hydrocephalus
- Patients with SAH without EVD.
- Patients with non-aneurysmal SAH.
- Pregnant or breastfeeding women.
- Patients under legal protection, guardianship, curatorship, safeguard of justice.
- Patients participating in a study that may interfere with the present study.
- Persons under forced psychiatric care.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary endpoint will be the change in CSF ionogram between day 0 and day 14 according to the occurrence of hyponatremia. The patient is included during hospitalization within 2 days of the placement of the EVD
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Hopital Femme Mère Enfant
🇫🇷Bron, France
Hopital Femme Mère Enfant🇫🇷Bron, FranceBaptiste BALANCA, MD, PhDPrincipal Investigator